Periostin: A Potential Therapeutic Target For Pulmonary Hypertension?

Circ Res. 2020 Oct 9;127(9):1138-1152. doi: 10.1161/CIRCRESAHA.120.316943. Epub 2020 Aug 5.

Abstract

Rationale: POSTN (Periostin) is an ECM (extracellular matrix) protein involved in tissue remodeling in response to injury and a contributing factor in tumorigenesis, suggesting that POSTN plays a role in the pathogenesis of pulmonary hypertension (PH).

Objective: We aimed to gain insight into the mechanistic contribution of POSTN in experimental mouse models of PH and correlate these findings with PH in humans.

Methods and results: We used genetic epistasis approaches in human pulmonary artery endothelial cells (hPAECs), human pulmonary artery smooth muscle cells, and experimental mouse models of PH (Sugen 5416/hypoxia or chronic hypoxia) to discern the role of POSTN and its relationship to HIF (hypoxia-inducible factor)-1α signaling. We found that POSTN expression was correlated with the extent of PH in mouse models and in humans. Decreasing POSTN improved hemodynamic and cardiac responses in PH mice, blunted the release of growth factors and HIF-1α, and reversed the downregulated BMPR (bone morphogenetic protein receptor)-2 expression in hPAECs from patients with PH, whereas increasing POSTIN had the opposite effects and induced a hyperproliferative and promigratory phenotype in both hPAECs and human pulmonary artery smooth muscle cells. Overexpression of POSTN-induced activation of HIFs and increased the production of ET (endothelin)-1 and VEGF (vascular endothelial growth factor) in hPAECs. SiRNA-mediated knockdown of HIF-1α abolished the proangiogenic effect of POSTN. Blockade of TrkB (tyrosine kinase receptor B) attenuated the effect of POSTN on HIF-1α expression, while inhibition of HIF-1α reduced the expression of POSTN and TrkB. These results suggest that hPAECs produce POSTN via a HIF-1α-dependent mechanism.

Conclusions: Our study reveals that POSTN expression is increased in human and animal models of PH and fosters PH development via a positive feedback loop between HIF-1α and POSTN during hypoxia. We propose that manipulating POSTIN expression may be an efficacious therapeutic target in the treatment of PH. Our results also suggest that POSTN may serve as a biomarker to estimate the severity of PH.

Keywords: endothelial cells; extracellular matrix; hypoxia; phenotype; pulmonary arterial hypertension.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biomarkers / metabolism
  • Bone Morphogenetic Protein Receptors, Type II / metabolism
  • Cell Adhesion Molecules / metabolism*
  • Cell Hypoxia
  • Cell Movement
  • Cell Proliferation
  • Disease Models, Animal
  • Endothelial Cells / cytology
  • Endothelial Cells / physiology
  • Endothelin-1 / metabolism
  • Humans
  • Hypertension, Pulmonary / etiology
  • Hypertension, Pulmonary / metabolism*
  • Hypertension, Pulmonary / therapy
  • Hypoxia-Inducible Factor 1, alpha Subunit / genetics
  • Hypoxia-Inducible Factor 1, alpha Subunit / metabolism*
  • Indoles
  • Membrane Glycoproteins / antagonists & inhibitors
  • Mice
  • Myocytes, Smooth Muscle / cytology
  • Myocytes, Smooth Muscle / physiology
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • Pulmonary Artery / cytology
  • Pyrroles
  • Receptor, trkB / antagonists & inhibitors
  • Vascular Endothelial Growth Factor A / metabolism

Substances

  • Biomarkers
  • Cell Adhesion Molecules
  • Endothelin-1
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Indoles
  • Membrane Glycoproteins
  • POSTN protein, human
  • Postn protein, mouse
  • Pyrroles
  • Vascular Endothelial Growth Factor A
  • Semaxinib
  • Ntrk2 protein, mouse
  • Protein-Tyrosine Kinases
  • Receptor, trkB
  • tropomyosin-related kinase-B, human
  • BMPR2 protein, human
  • Bmpr2 protein, mouse
  • Bone Morphogenetic Protein Receptors, Type II